GRI BIO, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GRI BIO, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $1.34M.
- GRI BIO, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $6.50M.
- GRI BIO, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $1.03M.
- GRI BIO, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $4.13M.
- GRI BIO, INC. stock issued during period, value, new issues for fiscal 2024 was $11.17M.
- GRI BIO, INC. stock issued during period, value, new issues for fiscal 2022 was $2.16M, a 85.69% decline from fiscal 2021.
- GRI BIO, INC. stock issued during period, value, new issues for fiscal 2021 was $15.10M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $1.34M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $6.50M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $11.17M 10-K · filed 2026-01-30 | |
| 2024-09-30 | $1.03M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $4.13M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $4.39M 10-Q · filed 2025-08-14 | |
| 2022-12-31 | $2.16M 10-K · filed 2023-02-24 | |
| 2022-06-30 | $2.16M 10-Q · filed 2022-11-03 | |
| 2021-12-31 | $15.10M 10-K · filed 2023-02-24 | |
| 2021-03-31 | $15.10M 10-Q · filed 2022-11-03 |